Cargando…
In Vivo MRI Tracking of Mesenchymal Stromal Cells Labeled with Ultrasmall Paramagnetic Iron Oxide Particles after Intramyocardial Transplantation in Patients with Chronic Ischemic Heart Disease
BACKGROUND: While regenerative stem cell therapy for ischemic heart disease has moved into phase 3 studies, little is still known about retention and migration of cell posttransplantation. In human studies, the ability to track transplanted cells has been limited to labeling with radioisotopes and t...
Autores principales: | Mathiasen, Anders Bruun, Qayyum, Abbas Ali, Jørgensen, Erik, Helqvist, Steffen, Ekblond, Annette, Ng, Michael, Bhakoo, Kishore, Kastrup, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877937/ https://www.ncbi.nlm.nih.gov/pubmed/31814830 http://dx.doi.org/10.1155/2019/2754927 |
Ejemplares similares
-
Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results
por: Qayyum, Abbas Ali, et al.
Publicado: (2019) -
Optimal Labeling Dose, Labeling Time, and Magnetic Resonance Imaging Detection Limits of Ultrasmall Superparamagnetic Iron-Oxide Nanoparticle Labeled Mesenchymal Stromal Cells
por: Mathiasen, Anders Bruun, et al.
Publicado: (2013) -
Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study
por: Qayyum, Abbas Ali, et al.
Publicado: (2017) -
Cryopreserved Off‐the‐Shelf Allogeneic Adipose‐Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure—A Safety Study
por: Kastrup, Jens, et al.
Publicado: (2017) -
Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure
por: Qayyum, Abbas Ali, et al.
Publicado: (2023)